Annual Current Liabilities
$14.55 M
+$4.83 M+49.73%
31 December 2023
Summary:
Cytosorbents annual total current liabilities is currently $14.55 million, with the most recent change of +$4.83 million (+49.73%) on 31 December 2023. During the last 3 years, it has risen by +$4.39 million (+43.26%). CTSO annual current liabilities is now at all-time high.CTSO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$8.43 M
-$1.91 M-18.44%
30 September 2024
Summary:
Cytosorbents quarterly total current liabilities is currently $8.43 million, with the most recent change of -$1.91 million (-18.44%) on 30 September 2024. Over the past year, it has dropped by -$3.54 million (-29.59%). CTSO quarterly current liabilities is now -51.43% below its all-time high of $17.36 million, reached on 30 September 2020.CTSO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.7% | -29.6% |
| 3 y3 years | +43.3% | -23.9% |
| 5 y5 years | +110.3% | -9.4% |
CTSO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +49.7% | -42.5% | at low |
| 5 y | 5 years | at high | +110.3% | -51.4% | at low |
| alltime | all time | at high | +1503.9% | -51.4% | +9947.9% |
Cytosorbents Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.43 M(-18.4%) |
| June 2024 | - | $10.34 M(-23.0%) |
| Mar 2024 | - | $13.42 M(-7.7%) |
| Dec 2023 | $14.55 M(+49.7%) | $14.55 M(+21.5%) |
| Sept 2023 | - | $11.97 M(+15.7%) |
| June 2023 | - | $10.35 M(-0.8%) |
| Mar 2023 | - | $10.44 M(+7.4%) |
| Dec 2022 | $9.71 M(-29.0%) | $9.71 M(-4.0%) |
| Sept 2022 | - | $10.12 M(-4.1%) |
| June 2022 | - | $10.55 M(-28.1%) |
| Mar 2022 | - | $14.67 M(+7.2%) |
| Dec 2021 | $13.69 M(+34.8%) | $13.69 M(+23.7%) |
| Sept 2021 | - | $11.07 M(+2.5%) |
| June 2021 | - | $10.80 M(+10.6%) |
| Mar 2021 | - | $9.76 M(-3.9%) |
| Dec 2020 | $10.15 M(+2.2%) | $10.15 M(-41.5%) |
| Sept 2020 | - | $17.36 M(+10.8%) |
| June 2020 | - | $15.66 M(+36.6%) |
| Mar 2020 | - | $11.46 M(+15.4%) |
| Dec 2019 | $9.94 M(+43.7%) | $9.94 M(+6.8%) |
| Sept 2019 | - | $9.30 M(+34.4%) |
| June 2019 | - | $6.92 M(+3.1%) |
| Mar 2019 | - | $6.71 M(-3.0%) |
| Dec 2018 | $6.92 M(-11.9%) | $6.92 M(+62.3%) |
| Sept 2018 | - | $4.26 M(+22.1%) |
| June 2018 | - | $3.49 M(-12.4%) |
| Mar 2018 | - | $3.99 M(-49.2%) |
| Dec 2017 | $7.85 M(+83.5%) | $7.85 M(+35.8%) |
| Sept 2017 | - | $5.78 M(-7.3%) |
| June 2017 | - | $6.23 M(+0.8%) |
| Mar 2017 | - | $6.18 M(+44.5%) |
| Dec 2016 | $4.28 M(+40.6%) | $4.28 M(-14.4%) |
| Sept 2016 | - | $5.00 M(+27.1%) |
| June 2016 | - | $3.93 M(+21.1%) |
| Mar 2016 | - | $3.25 M(+6.7%) |
| Dec 2015 | $3.04 M | $3.04 M(-11.7%) |
| Sept 2015 | - | $3.45 M(+36.4%) |
| June 2015 | - | $2.53 M(-59.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $6.20 M(+37.6%) |
| Dec 2014 | $4.51 M(+47.0%) | $4.51 M(+190.8%) |
| Sept 2014 | - | $1.55 M(-44.1%) |
| June 2014 | - | $2.77 M(-16.0%) |
| Mar 2014 | - | $3.30 M(+7.6%) |
| Dec 2013 | $3.06 M(+47.6%) | $3.06 M(-0.0%) |
| Sept 2013 | - | $3.07 M(+45.7%) |
| June 2013 | - | $2.10 M(+111.8%) |
| Mar 2013 | - | $993.40 K(-52.2%) |
| Dec 2012 | $2.08 M(+35.9%) | $2.08 M(+0.0%) |
| Sept 2012 | - | $2.08 M(-9.9%) |
| June 2012 | - | $2.30 M(+2.5%) |
| Mar 2012 | - | $2.25 M(+47.2%) |
| Dec 2011 | $1.53 M(+25.3%) | $1.53 M(-3.8%) |
| Sept 2011 | - | $1.59 M(+12.0%) |
| June 2011 | - | $1.42 M(+15.3%) |
| Mar 2011 | - | $1.23 M(+0.9%) |
| Dec 2010 | $1.22 M(+25.6%) | $1.22 M(-40.2%) |
| Sept 2010 | - | $2.04 M(+66.4%) |
| June 2010 | - | $1.22 M(-7.3%) |
| Mar 2010 | - | $1.32 M(+36.1%) |
| Dec 2009 | $970.80 K(-0.7%) | $970.80 K(+6.0%) |
| Sept 2009 | - | $915.80 K(-0.4%) |
| June 2009 | - | $919.80 K(+3.0%) |
| Mar 2009 | - | $893.10 K(-8.7%) |
| Dec 2008 | $977.70 K(+7.8%) | $977.70 K(+4.8%) |
| Sept 2008 | - | $932.50 K(-20.8%) |
| June 2008 | - | $1.18 M(+3.4%) |
| Mar 2008 | - | $1.14 M(+25.5%) |
| Dec 2007 | $906.90 K(-16.2%) | $906.90 K(+4.0%) |
| Sept 2007 | - | $872.40 K(-43.0%) |
| June 2007 | - | $1.53 M(+6.7%) |
| Mar 2007 | - | $1.43 M(+32.6%) |
| Dec 2006 | $1.08 M | $1.08 M(-54.9%) |
| Sept 2006 | - | $2.40 M(-34.9%) |
| June 2006 | - | $3.69 M(+3566.9%) |
| Feb 2006 | - | $100.50 K(+9.2%) |
| Nov 2005 | - | $92.00 K(+9.7%) |
| Aug 2005 | - | $83.90 K |
FAQ
- What is Cytosorbents annual total current liabilities?
- What is the all time high annual current liabilities for Cytosorbents?
- What is Cytosorbents annual current liabilities year-on-year change?
- What is Cytosorbents quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cytosorbents?
- What is Cytosorbents quarterly current liabilities year-on-year change?
What is Cytosorbents annual total current liabilities?
The current annual current liabilities of CTSO is $14.55 M
What is the all time high annual current liabilities for Cytosorbents?
Cytosorbents all-time high annual total current liabilities is $14.55 M
What is Cytosorbents annual current liabilities year-on-year change?
Over the past year, CTSO annual total current liabilities has changed by +$4.83 M (+49.73%)
What is Cytosorbents quarterly total current liabilities?
The current quarterly current liabilities of CTSO is $8.43 M
What is the all time high quarterly current liabilities for Cytosorbents?
Cytosorbents all-time high quarterly total current liabilities is $17.36 M
What is Cytosorbents quarterly current liabilities year-on-year change?
Over the past year, CTSO quarterly total current liabilities has changed by -$3.54 M (-29.59%)